MARVEL TALES #131

Cover shows strong gloss and vivid color with sharp corners overall; a small crease/tear is visible at the lower left edge near the barcode, and there are minor edge wear points along the left and bottom margins. No major spine stress lines or color breaks are apparent, though the book is in a protective sleeve which slightly obscures fine surface detail. Interior pages and back cover were not assessed.

Marvel Tales #131 is part of the long-running Marvel Tales reprint line, which through the late 1970s and early 1980s republished Amazing Spider-Man issues roughly in step with their original numbering. This issue reprints the story from Amazing Spider-Man #131 (April 1974), written by Gerry Conway with art by Ross Andru, in which scientist Simon Maddicks debuts as the winged villain the Griffin. The story also continues subplots involving Peter Parker's personal life, including his relationship with Mary Jane Watson and ongoing concern for Aunt May, staples of the Conway-Andru run.

As a reprint title, Marvel Tales #131 was produced and distributed as an affordable alternative to back-issue Amazing Spider-Man, and it was priced and sold accordingly at newsstands in 1981. It does not carry the collector premium attached to the original Amazing Spider-Man #131, since first appearances and other key story elements are credited to the issue in which they originally appeared rather than to later reprints. Demand for this issue is limited mainly to Marvel Tales completists and Spider-Man reprint-run collectors rather than character-first-appearance buyers.

This book trades as a common Bronze Age reprint: readily available in the raw back-issue market at modest prices across most grades, with only high-grade certified copies commanding a meaningful premium due to the scarcity of well-preserved newsstand copies rather than any inherent story significance. Collectors building a complete Marvel Tales run, or those seeking an affordable way to read the Griffin's debut story, are the primary audience; it holds little appeal as a standalone investment piece.